Purpose: Radical resection is paramount for curative oncological surgery. Fluorescence-guided surgery (FGS) aids in intraoperative identification of tumor-positive resection margins. This study aims to assess the feasibility of urokinase plasminogen activator receptor (uPAR) targeting antibody fragments for FGS in a direct comparison with their parent IgG in various relevant in vivo models. Procedures: Humanized anti-uPAR monoclonal antibody MNPR-101 (uIgG) was proteolytically digested into F(ab’)2 and Fab fragments named uFab2 and uFab. Surface plasmon resonance (SPR) and cell assays were used to determine in vitro binding before and after fluorescent labeling with IRDye800CW. Mice bearing subcutaneous HT-29 human colonic cancer cells were...
Purpose: Intraoperative optical imaging to guide surgeons during oncologic resections offers a uniqu...
International audienceBACKGROUND:Near-infrared (NIR) fluorescence is a promising novel imaging techn...
Pancreatic cancer is a recalcitrant disease in which R0 resection is often not achieved owing to dif...
Purpose Radical resection is paramount for curative oncological surgery. Fluorescence-guided surgery...
Pre- and intraoperative diagnostic techniques facilitating tumor staging are of paramount importance...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Clinical imaging performance using a fluorescent antibody was compared across 3 cancers to elucidate...
With a 5-year recurrence rate of 30–78%, urothelial cell carcinoma (UCC) rates amongst the highest o...
International audiencePURPOSE:Fluorescence-guided surgery (FGS) provides surgeons with new opportuni...
Pancreatic cancer (PDAC) is an extremely lethal disease with an overall survival rate of 10%. Surger...
textabstractBackground: Evaluation of resection margins during cancer surgery can be challenging, of...
The urokinase plasminogen activator receptor (uPAR) is involved in the proliferation and migration o...
BackgroundWe have developed a method of distinguishing normal tissue from pancreatic cancer in vivo ...
In 1944 Albert Coons was the first to show that a fluorescent molecule could be conjugated directly ...
PURPOSE: Tumor targeted optical imaging using antibodies labeled with near infrared fluorophores is ...
Purpose: Intraoperative optical imaging to guide surgeons during oncologic resections offers a uniqu...
International audienceBACKGROUND:Near-infrared (NIR) fluorescence is a promising novel imaging techn...
Pancreatic cancer is a recalcitrant disease in which R0 resection is often not achieved owing to dif...
Purpose Radical resection is paramount for curative oncological surgery. Fluorescence-guided surgery...
Pre- and intraoperative diagnostic techniques facilitating tumor staging are of paramount importance...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Clinical imaging performance using a fluorescent antibody was compared across 3 cancers to elucidate...
With a 5-year recurrence rate of 30–78%, urothelial cell carcinoma (UCC) rates amongst the highest o...
International audiencePURPOSE:Fluorescence-guided surgery (FGS) provides surgeons with new opportuni...
Pancreatic cancer (PDAC) is an extremely lethal disease with an overall survival rate of 10%. Surger...
textabstractBackground: Evaluation of resection margins during cancer surgery can be challenging, of...
The urokinase plasminogen activator receptor (uPAR) is involved in the proliferation and migration o...
BackgroundWe have developed a method of distinguishing normal tissue from pancreatic cancer in vivo ...
In 1944 Albert Coons was the first to show that a fluorescent molecule could be conjugated directly ...
PURPOSE: Tumor targeted optical imaging using antibodies labeled with near infrared fluorophores is ...
Purpose: Intraoperative optical imaging to guide surgeons during oncologic resections offers a uniqu...
International audienceBACKGROUND:Near-infrared (NIR) fluorescence is a promising novel imaging techn...
Pancreatic cancer is a recalcitrant disease in which R0 resection is often not achieved owing to dif...